HI
CTSO icon

Harbour Investments’s Cytosorbents Corp CTSO Stock Holding History

Harbour Investments’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-75
Closed -$1K – 3779
2021
Q2 		$1K Hold
75
– – ﹤0.01% 3521
2021
Q1 		$1K Buy
+75
New +$715 ﹤0.01% 3349

Other funds holding CTSO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Harbour Investments's CTSO Position: Q3 2021 in Review

Harbour Investments sold out of Cytosorbents Corp (CTSO) in Q3 2021, closing a stake of 75 shares — an estimated $1K sold.

Harbour Investments first reported a position in CTSO in Q1 2021 and held it in 2 quarters. The position peaked at $1K in Q2 2021. 96 funds tracked by Wall St. Rank hold CTSO as of Q3 2021.

  • Harbour Investments reported no remaining Cytosorbents Corp position as of Q3 2021 after selling out during the quarter.
  • Harbour Investments sold 75 Cytosorbents Corp shares in Q3 2021, an estimated $1K.
  • Harbour Investments first reported a position in Cytosorbents Corp in Q1 2021 and held it in 2 quarters.
  • Harbour Investments's Cytosorbents Corp position peaked at $1K in Q2 2021.
  • 96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q3 2021.

Based on Harbour Investments's 13F filing for Q3 2021, filed 15 Nov 2021.